CyMedica Orthopedics develops and commercializes products that target joint injuries and the resulting muscle atrophy.
CyMedica has raised $2.9M in total funding. The most recent round was Debt Financing. The last funding was announced in November 2023.
CyMedica's investors include Aphelion Capital, California Technology Ventures, Research Corporation Technologies.
CyMedica is headquartered in Tempe, United States.
CyMedica Orthopedics develops and commercializes products that target joint injuries and the resulting muscle atrophy.
CyMedica is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CyMedica — Funding & Investors." VCBacked, November 16, 2023, https://www.vcbacked.co/company/cymedica. Accessed August 14, 2026.
VCBacked. (2023). CyMedica — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cymedica
{{cite web |title=CyMedica — Funding & Investors |url=https://www.vcbacked.co/company/cymedica |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated